These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

61 related articles for article (PubMed ID: 888354)

  • 1. Tubular aggregation of coxsackievirus B5 in HeLa cells.
    Shahrabadi MS; Morgante O
    Virology; 1977 Jul; 80(2):434-40. PubMed ID: 888354
    [No Abstract]   [Full Text] [Related]  

  • 2. Inhibition of the uncoating of bovine enterovirus by short chain fatty acids.
    Ismail-Cassim N; Chezzi C; Newman JF
    J Gen Virol; 1990 Oct; 71 ( Pt 10)():2283-9. PubMed ID: 2172446
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Studies on the interaction between coxsackievirus A9 and HeLa cells. II. Mode of growth of coxsackievirus A9 in HeLa cell cultures and the effect of sulfated polysaccharide on plaque formation.
    Matsumoto M; Nakano M; Tagaya I
    Jpn J Med Sci Biol; 1976 Apr; 29(2):77-90. PubMed ID: 184326
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Coxsackievirus infection in skeletal muscles of mice. An electron microscopic study. II. Appearance and fate of virus progeny.
    Bienz K; Bienz-Isler G; Egger D; Weiss M; Loeffler H
    Arch Gesamte Virusforsch; 1970; 31(3):257-65. PubMed ID: 4923321
    [No Abstract]   [Full Text] [Related]  

  • 5. Studies on the interaction between coxsackievirus A9 and HeLa cells. I. Plaque-forming ability of coxsackievirus A9 in HeLa cell cultures.
    Matsumoto M; Nakano M; Nishikawa F; Tagaya I
    Jpn J Med Sci Biol; 1976 Apr; 29(2):67-76. PubMed ID: 184325
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Elution and uncoating of Coxsackievirus B3 by isolated HeLa cell plasma membranes.
    Roesing TG; Toselli PA; Crowell RL
    J Virol; 1975 Mar; 15(3):654-7. PubMed ID: 123011
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Virus enhancement with a growth product of Streptomyces scabies. II. Increased release of coxsackievirus B5 from HEp-2 monolayers treated with scaben.
    Konowalchuk J; Speirs JI
    Can J Microbiol; 1968 Oct; 14(10):1111-4. PubMed ID: 5681522
    [No Abstract]   [Full Text] [Related]  

  • 8. Variation in susceptibility of HeLa cell lines to coxsackievirus A9.
    Matsumoto M; Mukai M; Tagaya I
    Arch Virol; 1979; 59(3):213-22. PubMed ID: 222235
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Multiplication of Coxsackie B1 virus in synchronized HeLa cells.
    Suarez M; Contreras G; Fridlender B
    J Virol; 1975 Nov; 16(5):1337-9. PubMed ID: 1185854
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Morphogenesis of the assembly and release of bovine enterovirus.
    Yilma T; Breese SS
    J Gen Virol; 1980 Jul; 49(1):225-30. PubMed ID: 6252289
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Enterovirus replication in porcine ileal explants.
    Heinz BA; Cliver DO; Donohoe B
    J Gen Virol; 1987 Sep; 68 ( Pt 9)():2495-9. PubMed ID: 2821187
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The enhanced release of coxsackievirus B5 from a trypsinized monolayer of Hep-2 cells.
    Konowalchuk J; Speirs JI
    Can J Microbiol; 1968 Feb; 14(2):119-23. PubMed ID: 5644403
    [No Abstract]   [Full Text] [Related]  

  • 13. Nitric oxide inhibition of coxsackievirus replication in vitro.
    Zaragoza C; Ocampo CJ; Saura M; McMillan A; Lowenstein CJ
    J Clin Invest; 1997 Oct; 100(7):1760-7. PubMed ID: 9312175
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Comparison of proliferation and cytopathogenicity of swine vesicular virus and coxsackievirus B5.
    Lai SS; Breese SS; Moore DM; Gillespie JH
    Zhonghua Min Guo Wei Sheng Wu Ji Mian Yi Xue Za Zhi; 1981 Sep; 14(3):167-72. PubMed ID: 6269809
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The efficacy of simulated solar disinfection (SODIS) against coxsackievirus, poliovirus and hepatitis A virus.
    Heaselgrave W; Kilvington S
    J Water Health; 2012 Dec; 10(4):531-8. PubMed ID: 23165710
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Broad-range inhibition of enterovirus replication by OSW-1, a natural compound targeting OSBP.
    Albulescu L; Strating JR; Thibaut HJ; van der Linden L; Shair MD; Neyts J; van Kuppeveld FJ
    Antiviral Res; 2015 May; 117():110-4. PubMed ID: 25752737
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Organ culture of human aorta: prolonged survival with support of viral replication.
    Blacklow NR; Rose FB; Whalen RA
    J Infect Dis; 1975 May; 131(5):575-8. PubMed ID: 165246
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Studies on plaque variants of coxsackievirus B5 by burst analyses.
    Konowalchuk J; Speirs JI
    Can J Microbiol; 1967 Feb; 13(2):167-72. PubMed ID: 6035534
    [No Abstract]   [Full Text] [Related]  

  • 19. Coxsackievirus B3 replication is reduced by inhibition of the extracellular signal-regulated kinase (ERK) signaling pathway.
    Luo H; Yanagawa B; Zhang J; Luo Z; Zhang M; Esfandiarei M; Carthy C; Wilson JE; Yang D; McManus BM
    J Virol; 2002 Apr; 76(7):3365-73. PubMed ID: 11884562
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Efficient replication of recombinant Enterovirus B types, carrying different P1 genes in the coxsackievirus B5 replicative backbone.
    Jonsson N; Sävneby A; Gullberg M; Evertsson K; Klingel K; Lindberg AM
    Virus Genes; 2015 Jun; 50(3):351-7. PubMed ID: 25663145
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.